NP47924 Cytokine Modulators

A Tender Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Goods)
Duration
23.5 month
Value
£23M
Sector
HEALTH
Published
01 Nov 2024
Delivery
To 22 Nov 2026 (est.)
Deadline
02 Dec 2024 12:00

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 0 suppliers
NHS National Services Scotland NSS
+−
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

1 buyer

Description

Supply of Cytokine Modulators to NHS Scotland.

Lot Division

1 Etanercept
  • Value: £11M

Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
2 Infliximab IV
  • Value: £6M

Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
3 Infliximab SC
  • Value: £1M

Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
4 Methotrexate syringes (25mg/1 ml concentration)
  • Value: £58K

Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
5 Methotrexate pens (25mg/1ml concentration)
  • Value: £57K

Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
6 Methotrexate pens (50mg/1 ml concentration)
  • Value: £4M

Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
7 Methotrexate syringes (50mg/1ml concentration)
  • Value: £102K

Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal Options

This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award Criteria

API Sources 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • This is a one-off contract (no recurrence)
  • Renewals are available.
  • Technical restrictions apply.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 27889. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-pr... A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework. Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-com...). (SC Ref:781799)

Reference

Domains